Madrigal Pharmaceuticals, Inc. (MDGL)
NASDAQ: MDGL · Real-Time Price · USD
443.10
+18.87 (4.45%)
At close: Sep 29, 2025, 4:00 PM EDT
444.00
+0.90 (0.20%)
After-hours: Sep 29, 2025, 5:55 PM EDT

Madrigal Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
9,8766,7304,5685,1791,4491,719
Upgrade
Market Cap Growth
95.22%47.33%-11.79%257.45%-15.74%22.31%
Upgrade
Enterprise Value
9,2035,8514,4525,0751,1511,384
Upgrade
Last Close Price
443.10308.57231.38290.2584.74111.17
Upgrade
PS Ratio
18.9137.36----
Upgrade
PB Ratio
14.158.9211.2726.247.397.17
Upgrade
P/TBV Ratio
14.288.9811.2726.247.397.17
Upgrade
EV/Sales Ratio
17.8532.48----
Upgrade
Debt / Equity Ratio
0.180.160.290.250.000.00
Upgrade
Asset Turnover
0.490.21----
Upgrade
Quick Ratio
4.465.795.353.103.526.10
Upgrade
Current Ratio
5.116.105.383.123.546.13
Upgrade
Return on Equity (ROE)
-36.30%-80.35%-123.98%-150.12%-110.92%-61.61%
Upgrade
Return on Assets (ROA)
-18.31%-36.98%-47.41%-57.71%-54.09%-35.44%
Upgrade
Return on Capital (ROIC)
-21.57%-44.56%-61.78%-82.62%-69.25%-39.26%
Upgrade
Earnings Yield
-2.85%-6.92%-8.18%-5.70%-16.69%-11.76%
Upgrade
FCF Yield
-3.12%-6.79%-7.13%-4.35%-12.71%-9.18%
Upgrade
Buyback Yield / Dilution
-10.46%-13.83%-9.05%-3.64%-7.05%-0.34%
Upgrade
Updated Aug 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q